Guest Host: Steve Roberts

Vioxx, antidepressants, and a new FDA drug safety board are all on the agenda as Steve Roberts leads a discussion about the Food and Drug Administration and how well it is protecting consumers.

Guests

  • Dr. Jerry Avorn author of "Powerful Medicines," professor of medicine at Harvard Medical School, and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital in Boston
  • Marc Kaufman reporter on the national desk of "The Washington Post"
  • Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Efforts to Improve The Way We Die

Friday, Feb 17 2017Diane speaks with Dr. Roger Kligler who is living with advanced stage cancer on why he's suing the state of Massachusetts for the 'Right to Die' and with Dr. Jessica Zitter, and intensive care and palliative care specialist on why better communication is so needed between doctors and patients facing end-of-life issues.

Two Weeks In: The U.S. Government Under President Trump

Friday, Feb 03 2017President Trump announces his nominee for the Supreme Court, legal battles ramp up in opposition to the Trump's executive order on immigration restrictions,and some in Congress vow to resist: Three political experts speculate on the future of our three branches of government and their respective powers in the Trump administration.